We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+23.95%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.74B
AUM Growth
+$946M
Cap. Flow
+$105M
Cap. Flow %
1.56%
Top 10 Hldgs %
63.65%
Holding
393
New
188
Increased
79
Reduced
42
Closed
65

Top Buys

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$76M
2
NVO
Novo Nordisk
NVO
+$43.1M
3
FRPT icon
Freshpet
FRPT
+$41.5M
4
SBUX icon
Starbucks
SBUX
+$31.9M
5
BMY icon
Bristol-Myers Squibb
BMY
+$30.3M

Top Sells

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$79.6M
2
PTCT icon
PTC Therapeutics
PTCT
+$76M
3
GRFS
Grifois
GRFS
+$50.6M
4
STAA icon
STAAR Surgical
STAA
+$47.2M
5
TVTX icon
Travere Therapeutics
TVTX
+$40.5M

Sector Composition

Rank Sector Weight
1 Healthcare 31.9%
2 Technology 5.53%
3 Consumer Discretionary 5.27%
4 Communication Services 2.01%
5 Consumer Staples 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHW icon
176
Sherwin-Williams
SHW
$88.8B
$863K 0.01%
2,492
-10,008
-80% -$3.53M
JSPR icon
177
Jasper Therapeutics
JSPR
$22.5M
$828K 0.01%
+348,000
New +$1.06M
SNGX icon
178
Soligenix
SNGX
$5.69M
$821K 0.01%
+708,000
New +$1.63M
C icon
179
Citigroup
C
$228B
$821K 0.01%
+8,091
New +$768K
XRT icon
180
State Street SPDR S&P Retail ETF
XRT
$324M
$798K 0.01%
9,262
+4,392
+90% +$366K
BN icon
181
Brookfield
BN
$108B
$787K 0.01%
+17,216
New +$763K
REZI icon
182
Resideo Technologies
REZI
$4.01B
$768K 0.01%
+17,781
New +$555K
FSK icon
183
FS KKR Capital
FSK
$3.33B
$763K 0.01%
+51,099
New +$967K
HRB icon
184
H&R Block
HRB
$5.78B
$734K 0.01%
+14,506
New +$767K
TYL icon
185
Tyler Technologies
TYL
$12.4B
$731K 0.01%
+1,397
New +$784K
MPC icon
186
Marathon Petroleum
MPC
$84.4B
$730K 0.01%
+3,785
New +$666K
ADC icon
187
Agree Realty
ADC
$9.45B
$710K 0.01%
+10,001
New +$724K
FG icon
188
F&G Annuities & Life
FG
$3.78B
$705K 0.01%
+22,541
New +$745K
BIRK icon
189
Birkenstock
BIRK
$6.86B
$679K 0.01%
+15,012
New +$735K
SFD
190
Smithfield Foods
SFD
$9.88B
$674K 0.01%
+28,707
New +$702K
CME icon
191
CME Group
CME
$95.1B
$658K 0.01%
2,437
+1,485
+156% +$404K
PNC icon
192
PNC Financial Services
PNC
$102B
$649K 0.01%
+3,231
New +$639K
SKYW icon
193
Skywest
SKYW
$4.46B
$631K 0.01%
+6,276
New +$701K
LIF
194
Life360
LIF
$4.76B
$610K 0.01%
+5,734
New +$483K
ONON icon
195
On Holding
ONON
$12.5B
$609K 0.01%
+14,373
New +$684K
CAVA icon
196
CAVA Group
CAVA
$7.33B
$602K 0.01%
+9,966
New +$755K
QUCY
197
Quantum Cyber N.V.
QUCY
$31.9M
$588K 0.01%
394,519
+109,519
+38% +$184K
DAY
198
DELISTED
Dayforce
DAY
$576K 0.01%
+8,355
New +$520K
MELI icon
199
Mercado Libre
MELI
$90.6B
$575K 0.01%
246
-343
-58% -$823K
PSA icon
200
Public Storage
PSA
$61B
$570K 0.01%
+1,973
New +$566K
6 7
8
9 10

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Armistice Capital held 393 positions worth $6.74B, up 16% from $5.8B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Armistice Capital's Q3 2025 filing shows 188 new, 79 increased, 42 reduced and 65 closed positions. Its largest new stake was Novo Nordisk: 736,000 shares worth $40.8M. The largest sale was Supernus Pharmaceuticals, an estimated $79.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Armistice Capital's largest Q3 2025 buy was Novo Nordisk: 736,000 shares worth $40.8M.
  • Armistice Capital added most to Dentsply Sirona in Q3 2025, an estimated $76M increase.
  • Armistice Capital's biggest Q3 2025 reduction was Supernus Pharmaceuticals, cutting an estimated $79.6M.
  • Armistice Capital fully exited STAAR Surgical in Q3 2025, selling an estimated $47.2M.
  • Armistice Capital's ten largest holdings make up 64% of its $6.74B portfolio in Q3 2025.
  • Armistice Capital opened 188 new positions and closed 65 in Q3 2025.
  • Armistice Capital's portfolio value rose 16% quarter-over-quarter to $6.74B.

Based on Armistice Capital's 13F filing for Q3 2025, filed 17 Nov 2025.